학술논문

TLR2 bridges oxidative damage and complement-associated pathology and is a therapeutic target for age-related macular degeneration.
Document Type
Journal
Source
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE; JUL 2018, 59 9, 3p.
Subject
Language
English
ISSN
15525783